407.     Westerhoff K, McCarthy WH, Menzies SW. Increase in the sensitivity for melanoma diagnosis by primary care physicians using skin surface microscopy. Br J Dermatol 2000;143:1016-20.

406.     Uren RF, Thompson JF, Howman-Giles R. The history of lymphatic mapping. In: Nieweg OE, Essner R, Reintgen D, Thompson JF, eds. Lymphatic Mapping and Probe Applications in Oncology. New York: Marcel Dekker Inc; 2000:23-42.

405.     Uren RF, Thompson JF, Howman-Giles R. Sentinel nodes. Interval nodes, lymphatic lakes, and accurate sentinel node identification. Clin Nucl Med 2000;25:234-6.

404.     Uren RF, Howman-Giles R, Thompson JF, McCarthy WH, Quinn MJ, Roberts JM, Shaw HM. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg 2000;135:1168-72.

403.     Uren RF, Howman-Giles R, Thompson JF. Metastatic disease in the internal mammary lymph nodes has an adverse effect on patient prognosis and survival, regardless of axillary node status. Ann Surg Oncol 2000;7:790.

402.    Thompson JF, Uren RF. Standard and nonstandard applications of sentinel node-guided melanoma surgery. World J Surg 2000;24:494-5.

401.    Thompson JF, Uren RF. What is a 'sentinel' lymph node? Eur J Surg Oncol 2000;26:103-4.

400.    Thompson JF, Shaw HM. Sentinel node metastasis from thin melanomas with vertical growth phase. Ann Surg Oncol 2000;7:251-2.

399.    Thompson JF, Hunt JA, Culjak G, Uren RF, Howman-Giles R, Harman CR. Popliteal lymph node metastasis from primary cutaneous melanoma. Eur J Surg Oncol 2000;26:172-6.

398.    Thompson JF. Operative technique for sentinel lymphadenectomy:  blue dye identification and use of a gamma probe. In: Nieweg OE, Essner R, Reintgen D, Thompson JF, eds. Lymphatic Mapping and Probe Applications in Oncology. New York: Marcel Dekker Inc; 2000:71-86.

397.    Lymphoscintigraphy. Yourdoctor.com, 2000. (Accessed at Yourdoctor.com.)

396.    Stevens G, Thompson JF, Firth I, O'Brien CJ, McCarthy WH, Quinn MJ. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 2000;88:88-94.

395.    Shaw HM, Thompson JF. Regarding pedunculated malignant melanoma. Dermatol Surg 2000;26:812-4.

394.    Nieweg OE, Jansen L, Uren RF, Thompson JF. Instructive Cases. In: Nieweg OE, Essner R, Reintgen D, Thompson JF, eds. Lymphatic Mapping and Probe Applications in Oncology. New York: Marcel Dekker Inc; 2000:283-.

393.    Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCarthy WH, Katz B. Surface microscopy of pigmented basal cell carcinoma. Arch Dermatol 2000;136:1012-6.

392.    Menzies SW. The other Dr Finlay is commemorated in Cuban stamps. Bmj 2000;320:875.

391.    McCarthy WH. Evidence-based management of melanoma. Clinical practice guidelines are now available for managing this cancer which occurs in relatively young people and is a particular problem in Australia. Med J Aust 2000;173:286-7.

390.    Kam PCA, Thompson JF, Uren RF. Microanatomy and physiology of the lymphatic system. In: Nieweg OE, Essner R, Reintgen DS, Thompson JF, eds. Lymphatic Mapping and Probe Applications in Oncology. New York: Marcel Dekker Inc; 2000:1-22.

389.    Hanrahan PF, Menzies SW, D'Este CA, Plummer T, Hersey P. Participation of older males in a study on photography as an aid to early detection of melanoma. Aust N Z J Public Health 2000;24:615-8.

388.    Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton A, Jr., Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000;88:1484-91